Clinical Trial Update: The Influence of Plaquenil/Hydroxychloroquine (HCQ) on Insulin Secretion [Phase 1, Phase 2]

View source ↗

Summary

This entry notes a Phase 1/2 clinical trial evaluating hydroxychloroquine (Plaquenil) and its effect on insulin secretion in individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Plaquenil (hydroxychloroquine)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Diabetes Type Two | Phase 1, Phase 2 | Status: UNKNOWN